Committees’ opinions on application for authorisation available
The consolidated opinions of the Committees for Risk Assessment and Socio-economic Analysis for three uses of the 4-(1,1,3,3-tetramethylbutyl)phenol, ethoxylated are now available for:
- One use by Swedish Orphan Biovitrum;
- One use by DIAGAST; and
- One use by BioMérieux SA.